Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Current Deferred Revenue: 2020-2025

Historic Current Deferred Revenue for Maravai Lifesciences Holdings (MRVI) over the last 4 years, with Jun 2025 value amounting to $2.6 million.

  • Maravai Lifesciences Holdings' Current Deferred Revenue rose 21.16% to $2.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.6 million, marking a year-over-year increase of 21.16%. This contributed to the annual value of $3.3 million for FY2024, which is 40.00% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Current Deferred Revenue of $2.6 million as of Q2 2025, which was down 25.71% from $3.5 million recorded in Q1 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Current Deferred Revenue ranged from a high of $120.7 million in Q1 2021 and a low of $1.9 million during Q3 2024.
  • For the 3-year period, Maravai Lifesciences Holdings' Current Deferred Revenue averaged around $3.8 million, with its median value being $3.9 million (2024).
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first slumped by 95.61% in 2022, then rose by 21.16% in 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Current Deferred Revenue (Quarterly) stood at $12.6 million in 2021, then crashed by 61.90% to $4.8 million in 2022, then rose by 14.58% to $5.5 million in 2023, then tumbled by 40.00% to $3.3 million in 2024, then grew by 21.16% to $2.6 million in 2025.
  • Its last three reported values are $2.6 million in Q2 2025, $3.5 million for Q1 2025, and $3.3 million during Q4 2024.